19992018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marzia Adelia Locatelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 37 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer

Duso, B. A., Trapani, D., Viale, G., Criscitiello, C., D’Amico, P., Belli, C., Mazzarella, L., Locatelli, M., Minchella, I. & Curigliano, G., Feb 11 2018, In : Expert Opinion on Pharmacotherapy. 19, 3, p. 299-305 7 p.

Research output: Contribution to journalArticle

  • Entinostat for the treatment of breast cancer

    Trapani, D., Esposito, A., Criscitiello, C., Mazzarella, L., Locatelli, M., Minchella, I., Minucci, S. & Curigliano, G., Aug 3 2017, In : Expert Opinion on Investigational Drugs. 26, 8, p. 965-971 7 p.

    Research output: Contribution to journalArticle

  • Extended adjuvant chemotherapy in triple-negative breast cancer

    Locatelli, M. A., Curigliano, G. & Eniu, A., Jul 1 2017, In : Breast Care. 12, 3, p. 152-158 7 p.

    Research output: Contribution to journalReview article

  • Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triplenegative breast cancer

    Locatelli, M. A., Aftimos, P., Claire Dees, E., LoRusso, P. M., Pegram, M. D., Awada, A., Huang, B., Cesari, R., Jiang, Y., Shaik, M. N., Kern, K. A. & Curigliano, G., Jan 1 2017, In : Oncotarget. 8, 2, p. 2320-2328 9 p.

    Research output: Contribution to journalArticle